Chemotherapy-Induced Acral Erythema (Palmar-Plantar Erythrodysesthesia)

Epidemiology

  • xxx

Etiology

  • 5-Fluorouracil (5-FU) (see 5-Fluorouracil, [[5-Fluorouracil]])
  • Afatinib (Gilotrif) (se Afatinib, [[Afatinib]])
  • Axitinib (Inlyta) (see Axitinib, [[Axitinib]])
  • Capecitabine (Xeloda, Teva-Capecitabine) (see Capecitabine, [[Capecitabine]])
  • Cytarabine (Arabinofuranosyl Cytidine, ARA-C, Cytosine Arabinoside, Cytosar-U) (see Cytarabine, [[Cytarabine]])
  • Docetaxel (Taxotere) (see Docetaxel, [[Docetaxel]])
  • Doxorubicin (Adriamycin) (see Doxorubicin, [[Doxorubicin]]): liposomal
  • Pazopanib (Votrient) (see Pazopanib, [[Pazopanib]])
  • Sorafenib (Nexavar) (see Sorafenib, [[Sorafenib]])
  • Sunitinib (Sutent) (see Sunitinib, [[Sunitinib]])

Physiology

  • xxx

Diagnosis

  • xxx

Clinical Manifestations

Other Manifestations

  • xxx

Treatment

  • xxx

References

  • xxx